Literature DB >> 9665370

Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus.

Y M Smulders1, E H Slaats, M Rakic, F T Smulders, C D Stehouwer, J Silberbusch.   

Abstract

We determined the degree of variability and sampling distribution of several commonly used parameters of microalbuminuria in patients with non-insulin-dependent diabetes mellitus (NIDDM) and proposed a sampling strategy for estimating the level of albuminuria. Four patients with NIDDM with previously documented microalbuminuria collected 30 consecutive split (overnight and daytime) 24-hour urine samples (experiment A). These samples were analyzed for total 24-hour albumin excretion; daytime, overnight, and 24-hour albumin concentration; and daytime, overnight, and 24-hour albumin-to-creatinine ratio. In a second experiment (B), 10 patients collected 10 consecutive overnight urine samples. Finally, a total of 300 separate triplicate urine samples were analyzed for the variability of 24-hour albumin excretion (100 samples) and albumin-to-creatinine ratios in 24-hour urine (100 samples) and overnight urine (100 samples). We found that the sampling distribution shape of all parameters of albuminuria is positively skewed, without consistent evidence of log-normality. When two methods were used for quantifying day-to-day variability (the interquartile range/median ratio and the chance of a single measurement being >50% off the actual value of albuminuria), the overnight albumin-to-creatinine ratio is the least-variable parameter of albuminuria, scoring 0.38% and 10% on both methods, respectively, in experiment A. Collecting multiple samples of overnight urine improves accuracy. The largest gain in precision in estimating the actual value of albuminuria is obtained for sample sizes of three and five and does not increase with nonconsecutive sampling of urine. Based on the combined data from experiments A and B, the expected mean deviation of the median of three and five overnight samples from the actual level of the overnight albumin-creatinine ratio is 17.9% and 12.1%, respectively. An analysis of variability in three sets of 100 triplicate 24-hour urine samples shows that the overnight albumin-to-creatinine ratio is a significantly more-constant parameter of microalbuminuria than the amount of albumin excreted in 24 hours or the albumin-to-creatinine ratio in 24-hour urine (p < 0.05). We concluded that the parameters of diabetic albuminuria have positively skewed, non-log-normal sampling distributions. The overnight albumin-to-creatinine ratio is the least-variable parameter of microalbuminuria. We recommend collecting three consecutive early morning urine samples, using the median value of the albumin-to-creatinine ratio in these samples for quantifying albuminuria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665370     DOI: 10.1016/s0022-2143(98)90023-3

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

1.  Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease.

Authors:  Tobias F Kröpelin; Dick de Zeeuw; Giuseppe Remuzzi; Rudy Bilous; Hans-Henrik Parving; Hiddo J L Heerspink
Journal:  J Am Soc Nephrol       Date:  2016-04-07       Impact factor: 10.121

2.  Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy.

Authors:  Tobias F Kröpelin; Dick de Zeeuw; Dennis L Andress; Maarten J Bijlsma; Frederik Persson; Hans-Henrik Parving; Hiddo J Lambers Heerspink
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

3.  Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30-40 days of postnatal corrected age.

Authors:  Maria Cristina Aisa; Benito Cappuccini; Antonella Barbati; Aldo Orlacchio; Mauro Baglioni; Gian Carlo Di Renzo
Journal:  Pediatr Nephrol       Date:  2016-08-25       Impact factor: 3.714

4.  Cumulative systolic BP and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis.

Authors:  Paul Zemaitis; Kiang Liu; David R Jacobs; Mary Cushman; Ramon Durazo-Arvizu; David Shoham; Walter Palmas; Richard Cooper; Holly Kramer
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-08       Impact factor: 8.237

5.  Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.

Authors:  Amy K Mottl; John B Buse; Faramarz Ismail-Beigi; Ronald J Sigal; Carolyn F Pedley; Vasilios Papademetriou; Debra L Simmons; Lois Katz; Josyf C Mychaleckyj; Timothy E Craven
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-25       Impact factor: 8.237

6.  Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy.

Authors:  Alaa Alkhalaf; Petra Zürbig; Stephan J L Bakker; Henk J G Bilo; Marie Cerna; Christine Fischer; Sebastian Fuchs; Bart Janssen; Karel Medek; Harald Mischak; Johannes M Roob; Kasper Rossing; Peter Rossing; Ivan Rychlík; Harald Sourij; Beate Tiran; Brigitte M Winklhofer-Roob; Gerjan J Navis
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

7.  Microalbuminuria in normal Korean children.

Authors:  Byung Ok Kwak; Sang Taek Lee; Sochung Chung; Kyo Sun Kim
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

8.  Assessment of microalbuminuria for early diagnosis and risk prediction in dengue infections.

Authors:  Nguyen Thi Hanh Tien; Phung Khanh Lam; Huynh Thi Le Duyen; Tran Van Ngoc; Phan Thi Thanh Ha; Nguyen Tan Thanh Kieu; Cameron Simmons; Marcel Wolbers; Bridget Wills
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

9.  Consecutive first-morning urine samples to measure change in the albumin-to-creatinine ratio: a pilot study of a home urine collection protocol.

Authors:  Jessica M Sontrop; Amit X Garg; Lihua Li; Kerri Gallo; Virginia Schumann; Jennifer Winick-Ng; William F Clark; Matthew A Weir
Journal:  Can J Kidney Health Dis       Date:  2016-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.